Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

2.640 -0.230 (-8.01%)

Delayed Quote Updated: 12:10 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

PacBio (NASDAQ:PACB) Misses Q4 Sales Targets

February 13, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 32.8% year on year to $39.22 million. Its non-GAAP loss of...

Via StockStory

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

PacBio (PACB) Q4 Earnings Report Preview: What To Look For

February 12, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market hours. Here’s what investors should know.

Via StockStory

What Analysts Are Saying About Pacific Biosciences Stock ↗

January 23, 2025

Via Benzinga

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

January 07, 2025

With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025.

Via The Motley Fool

Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight ↗

December 05, 2024

Cathie Wood is investing in PacBio, a biotech company with potential for genomics revolution. ARK Invest is confident in its long-term growth.

Via Benzinga

What 5 Analyst Ratings Have To Say About Pacific Biosciences ↗

August 28, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Pacific Biosciences ↗

August 12, 2024

Via Benzinga

Peering Into Pacific Biosciences's Recent Short Interest ↗

August 08, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 04, 2024

Via Benzinga

Deciphering Disruption: Inside Cathie Wood's Latest Plays

November 16, 2024

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

Via MarketBeat

Topics Artificial Intelligence ETFs

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

November 12, 2024

The rock star money manager is starting to roll with the rallying market.

Via The Motley Fool

Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 08, 2024

Via Benzinga

Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 14, 2024

Via Benzinga

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket ↗

October 14, 2024

Via Benzinga

S&P 500 Moves Higher; BlackRock Reports Upbeat Results ↗

October 11, 2024

Via Benzinga

Topics Stocks

Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings ↗

October 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 11, 2024

Via Benzinga

Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday ↗

October 11, 2024

Via Benzinga

A Biotech Breakout Will Be Led By Small Caps ↗

September 23, 2024

It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever.

Via Talk Markets

Topics Artificial Intelligence Economy

Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Friday ↗

September 06, 2024

Via Benzinga

Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

August 16, 2024

Via Benzinga

PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024 ↗

August 07, 2024

PACB stock results show that Pacific Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm

August 02, 2024

From The Schall Law Firm

Via Business Wire

Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday? ↗

July 16, 2024

Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, certain that the Federal Reserve will begin cutting interest rates in...

Via Benzinga

Topics Economy Stocks

Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 16, 2024

Via Benzinga

UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday ↗

July 16, 2024

Via Benzinga

Strategic Buy Lights Up This Biotech Stock: Time to Invest?

July 16, 2024

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.

Via MarketBeat

Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday ↗

July 12, 2024

Via Benzinga

Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday ↗

July 11, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.